These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 14751504)

  • 41. Saposin C promotes survival and prevents apoptosis via PI3K/Akt-dependent pathway in prostate cancer cells.
    Lee TJ; Sartor O; Luftig RB; Koochekpour S
    Mol Cancer; 2004 Nov; 3():31. PubMed ID: 15548330
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Novel 2'-substituted, 3'-deoxy-phosphatidyl-myo-inositol analogues reduce drug resistance in human leukaemia cell lines with an activated phosphoinositide 3-kinase/Akt pathway.
    Tabellini G; Tazzari PL; Bortul R; Billi AM; Conte R; Manzoli L; Cocco L; Martelli AM
    Br J Haematol; 2004 Aug; 126(4):574-82. PubMed ID: 15287952
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Emerging roles of radioresistance in prostate cancer metastasis and radiation therapy.
    Chang L; Graham PH; Hao J; Bucci J; Cozzi PJ; Kearsley JH; Li Y
    Cancer Metastasis Rev; 2014 Sep; 33(2-3):469-96. PubMed ID: 24445654
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Different activation of mitogen-activated protein kinase and Akt signaling is associated with aggressive phenotype of human meningiomas.
    Mawrin C; Sasse T; Kirches E; Kropf S; Schneider T; Grimm C; Pambor C; Vorwerk CK; Firsching R; Lendeckel U; Dietzmann K
    Clin Cancer Res; 2005 Jun; 11(11):4074-82. PubMed ID: 15930342
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Biomarkers for assessment of pharmacologic activity for a vascular endothelial growth factor (VEGF) receptor inhibitor, PTK787/ZK 222584 (PTK/ZK): translation of biological activity in a mouse melanoma metastasis model to phase I studies in patients with advanced colorectal cancer with liver metastases.
    Lee L; Sharma S; Morgan B; Allegrini P; Schnell C; Brueggen J; Cozens R; Horsfield M; Guenther C; Steward WP; Drevs J; Lebwohl D; Wood J; McSheehy PM
    Cancer Chemother Pharmacol; 2006 Jun; 57(6):761-71. PubMed ID: 16172907
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Insulin-like growth factor I-mediated protection from rapamycin-induced apoptosis is independent of Ras-Erk1-Erk2 and phosphatidylinositol 3'-kinase-Akt signaling pathways.
    Thimmaiah KN; Easton J; Huang S; Veverka KA; Germain GS; Harwood FC; Houghton PJ
    Cancer Res; 2003 Jan; 63(2):364-74. PubMed ID: 12543789
    [TBL] [Abstract][Full Text] [Related]  

  • 47. High Efficacy of Combination Therapy Using PI3K/AKT Inhibitors with Androgen Deprivation in Prostate Cancer Preclinical Models.
    Marques RB; Aghai A; de Ridder CMA; Stuurman D; Hoeben S; Boer A; Ellston RP; Barry ST; Davies BR; Trapman J; van Weerden WM
    Eur Urol; 2015 Jun; 67(6):1177-1185. PubMed ID: 25220373
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mutant epidermal growth factor receptor signaling down-regulates p27 through activation of the phosphatidylinositol 3-kinase/Akt pathway in glioblastomas.
    Narita Y; Nagane M; Mishima K; Huang HJ; Furnari FB; Cavenee WK
    Cancer Res; 2002 Nov; 62(22):6764-9. PubMed ID: 12438278
    [TBL] [Abstract][Full Text] [Related]  

  • 49. PTEN augments staurosporine-induced apoptosis in PTEN-null Ishikawa cells by downregulating PI3K/Akt signaling pathway.
    Wan X; Yokoyama Y; Shinohara A; Takahashi Y; Tamaya T
    Cell Death Differ; 2002 Apr; 9(4):414-20. PubMed ID: 11965494
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Involvement of MAP-kinase, PI3-kinase and EGF-receptor in the stimulatory effect of Neurotensin on DNA synthesis in PC3 cells.
    Hassan S; Dobner PR; Carraway RE
    Regul Pept; 2004 Aug; 120(1-3):155-66. PubMed ID: 15177934
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Epidermal growth factor up-regulates expression of transforming growth factor beta receptor type II in human dermal fibroblasts by phosphoinositide 3-kinase/Akt signaling pathway: Resistance to epidermal growth factor stimulation in scleroderma fibroblasts.
    Yamane K; Ihn H; Tamaki K
    Arthritis Rheum; 2003 Jun; 48(6):1652-66. PubMed ID: 12794834
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Activation of mammalian target of rapamycin in transformed B lymphocytes is nutrient dependent but independent of Akt, mitogen-activated protein kinase/extracellular signal-regulated kinase kinase, insulin growth factor-I, and serum.
    Wlodarski P; Kasprzycka M; Liu X; Marzec M; Robertson ES; Slupianek A; Wasik MA
    Cancer Res; 2005 Sep; 65(17):7800-8. PubMed ID: 16140948
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Growth factor-independent activation of protein kinase B contributes to the inherent resistance of vascular endothelium to radiation-induced apoptotic response.
    Tan J; Hallahan DE
    Cancer Res; 2003 Nov; 63(22):7663-7. PubMed ID: 14633687
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Targeting the AKT/GSK3β/cyclin D1/Cdk4 survival signaling pathway for eradication of tumor radioresistance acquired by fractionated radiotherapy.
    Shimura T; Kakuda S; Ochiai Y; Kuwahara Y; Takai Y; Fukumoto M
    Int J Radiat Oncol Biol Phys; 2011 Jun; 80(2):540-8. PubMed ID: 21398050
    [TBL] [Abstract][Full Text] [Related]  

  • 55. VEGF secretion by neuroendocrine tumor cells is inhibited by octreotide and by inhibitors of the PI3K/AKT/mTOR pathway.
    Villaume K; Blanc M; Gouysse G; Walter T; Couderc C; Nejjari M; Vercherat C; Cordier-Bussat M; Roche C; Scoazec JY
    Neuroendocrinology; 2010; 91(3):268-78. PubMed ID: 20389030
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Combined treatment with EGFR inhibitors and arsenite upregulated apoptosis in human EGFR-positive melanomas: a role of suppression of the PI3K-AKT pathway.
    Ivanov VN; Hei TK
    Oncogene; 2005 Jan; 24(4):616-26. PubMed ID: 15580309
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The proangiogenic phenotype of human tumor-derived endothelial cells depends on thrombospondin-1 downregulation via phosphatidylinositol 3-kinase/Akt pathway.
    Bussolati B; Assenzio B; Deregibus MC; Camussi G
    J Mol Med (Berl); 2006 Oct; 84(10):852-63. PubMed ID: 16924472
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Angiopoietin-2 at high concentration can enhance endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway.
    Kim I; Kim JH; Moon SO; Kwak HJ; Kim NG; Koh GY
    Oncogene; 2000 Sep; 19(39):4549-52. PubMed ID: 11002428
    [TBL] [Abstract][Full Text] [Related]  

  • 59. PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis.
    Fang J; Ding M; Yang L; Liu LZ; Jiang BH
    Cell Signal; 2007 Dec; 19(12):2487-97. PubMed ID: 17826033
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Herceptin-induced inhibition of phosphatidylinositol-3 kinase and Akt Is required for antibody-mediated effects on p27, cyclin D1, and antitumor action.
    Yakes FM; Chinratanalab W; Ritter CA; King W; Seelig S; Arteaga CL
    Cancer Res; 2002 Jul; 62(14):4132-41. PubMed ID: 12124352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.